COMPARISON OF ORAL IRON SUPPLEMENTS (FERROUS SULPHATE) V/S PARENTRAL IRON SUPPLEMENT (IRON SUCROSE) IN ANTENATAL PATIENTS AT DHIRAJ GENERAL HOSPITAL, VADODARA

Abstract

Background: This study was carried out to compare the outcome of oral iron Ferrous sulphate tablets v/s parenteral Iron sucrose injection. Parenteral iron was more benecial in quickly restoring iron deciency in antenatal . Aim: To study outcome of comparison between oral and parenteral iron supplements in improving iron deciency anemia in pregnant women . Materials and Methods: This was a comparative and prospective study, conducted in Department of obstetrics and gynecology Dhiraj General hospital,Vadodara. Total 40 pregnant women with mild and moderate iron deciency anemia were taken as cases and followed up and study was conducted for 6 months. Results: Total 40 patients , 20 taking ferrous sulphate tablets and 20 given iv iron sucrose to avoid discrepancy , were studied for prevalence of iron deciency anemia . The anemic patients ranged from 20-35 years, of low socioeconomic status ,with prevalance in both the primigravida and multigravida, majorly in multigravida patients . Majority of patients were seen in 14-28 weeks gestation, which was timely managed in our setup. Majority of patients with iron deciency anemia had <50 kg weight , 13 of which had oral treatment, while 10 patients were given intravenous iron . Majority of women in this study had microcytic hypochromic iron deciency anemia with the nal mean hemoglobin after giving the treatment in oral group being less than in intravenous group . 15 patients (75%) in intravenous group and 13 patients ( 65%) in oral group did not have any side effects. Side effects like Gastrointestinal disturbance were seen more in oral group ( 5 patients i.e. 25%) while sweating and burning were seen in patients where intravenous treatment was given ( 2 patients i.e. 10%) and the nal mean hemoglobin in intravenous group is greater than the oral group. Thus, greater level of hemoglobin was achieved with intravenous mode in the same stipulated 6 months duration . Conclusion: The study depicts that intravenous iron is safe, convenient, and effective, without any serious side-effects , better tolerated by the patients with higher increase in mean hemoglobin. So, it's a good substitute to oral iron therapy in pregnant females with moderate anemia roughly at 14-28 weeks of gestation